Retroviral vector sequences may interact with some internal promoters and influence expression

Human Gene Therapy

Volumn 7, Issue 2, 1996, Pages 159-171

  Wu, Xiaoyun ^a   Holschen, Jolie ^a   Kennedy, Susan C ^a   Ponder, Katherine Parker ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENHANCER REGION; EXPRESSION VECTOR; FIBROBLAST; GENE EXPRESSION; GENE THERAPY; HEPATOMA CELL; LONG TERMINAL REPEAT; MOLECULAR CLONING; MOUSE; NONHUMAN; PROMOTER REGION; RETROVIRUS; TISSUE CULTURE;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0030066973     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.2-159     Document Type: Article

References (62)

1. AHEARN, J.M., BARTOLOMEI, M.S., WEST, M.L., CISEK, L.J., and CORDEN, J.L. (1987). Cloning and sequence analysis of the mouse genomic locus encoding the largest subunit of RNA polymerase II. J. Biol. Chem. 262, 10695-10705.
2. BABAJKO S., TRONCHE, F., and GROYER, A. (1993). Liver-specific expression of human insulin-like growth factor binding protein 1: Functional role of transcription factor HNF1 in vivo. Proc. Natl. Acad. Sci. 90, 272-276.
3. CEREGHINI, S., YANIV, M., and CORTESE, R. (1990). Hepatocyte dedifferentiation and extinction is accompanied by a block in the synthesis of mRNA coding for the transcription factor HNF1/LFB1. EMBO J. 9, 2257-2263.
4. CHALLITA, P.M., and KOHN, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated methylation in vivo. Proc. Natl. Acad. Sci. USA 91, 2567-2571.
5. CHALLITA, P-M, SKELTON, D., EL-KHOUEIRY, A., YU, X.-J., WEINBERG, K., and KOHN, D.B. (1995). Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol. 69, 748-755.
6. CHOMCZYNSHI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
7. CORRELL, P.H., COLILLA, S., and KARLSSON, S. (1994). Retroviral vector design for long-term expression in murine hematopoietic cells in vivo. Blood 84, 1812-1822.
8. COSTA, R.H., VAN DYKE, T.A., YAN, C., KUO, F., and DARNELL, J.E. (1990). Similarities in transthyretin gene expression and differences in transcription factors: Liver and yolk sac compared to choroid plexus. Proc Natl. Acad. Sci. USA 87, 6589-6593.
9. CRABTREE, G.R., SCHIBLER, U., and SCOTT, M.P. (1992). Transcriptional regulatory mechanisms in liver and midgut morphogenesis of vertebrates and invertebrates. In Transcriptional Regulation. K.R. Yamamoto and S.L. McKnight, eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
10. DARLINGTON, G. (1987). Liver cell lines. Methods Enzymol. 151, 19-38.
11. DENECKE, B., BARTKOWSKI, S., SENKEL, S., KLEIN-HITPASS, L., and RYFFEL, G.U. (1993). Chimeric liver transcription factors LFB1 (HNF1) containing the acidic activation domain of VP16 act as positive dominant interfering mutants. J. Biol. Chem. 268, 18076-18082.
12. DIPERSIO, C.M., JACKSON, D.A., and ZARET, K.S. (1991). The extracellular matrix coordinately modulated liver transcription factors and hepatocyte morphology. Mol. Cell. Biol. 11, 4405-4414.
13. FRAIN, M., SWART, G., MONACI, P., NICOSIA, A., STAMPFI, S., FRANK, R., AND CORTESE, R. (1989). The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell 59, 145-157.
14. FRAIN, M., HARDON, E., CILIBERTO, G., and SALA-TREPAT, J.M. (1990). Binding of a liver-specific factor to the albumin gene promoter and enhancer, Mol. Cell. Biol. 10, 991-999.
15. FRIEDMAN, A.D., LANDSCHULTZ, W.H., and McKNIGHT, S.L. (1989). CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes & Dev. 3, 1314-1322.
16. GE, R., RHEE, M., MALIK, S., and KARATHANASIS, S.K. (1994). Transcriptional repression of apolipoprotein AI gene expression by orphan receptor ARP-1, J. Biol. Chem. 18, 13185-13192.
17. GHATTAS, I.R., SANES, J.R., and MAJORS, J.E. (1991). The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11, 5848-5859.
18. GREZ, M., ZORING, M., NOWOCK, J., and ZIEGLER, M. (1991). A single point mutation activated the Moloney murine leukemia virus long terminal repeat in embryonic stem cells. J. Virol. 65, 4691-4698.
19. HAFENRICHTER, D.G., WU, X., RETTINGER, S.D., KENNEDY, S.C., FLYE, M.W., and PONDER, K.P. (1994). Quantitative evaluation of liver-specifc promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood 84, 3394-3404.
20. HATZOGLOU, M., LAMERS, W., BOSCH, F., WYNSHAW-BORIS, A., and HANSON, R. (1990). Hepatic gene transfer in animals using retroviruses containing the promoter for phosphoenolpyruvate carboxykinase. J. Biol. Chem. 265, 17285-17293.
21. HERBST, R.S., NIELSCH, U., SLADEK, F., LAI, E., BABISS, L.E., and DARNELL, J.E., Jr. (1991). Differential regulation of hepatocyte-enriched transcription factors explains changes in albumin and transthyretin gene expression among hepatoma cells. New Biol. 3, 289-296.
22. JAENISCH, R., SCHNIEKE, A., and HARBERS, K. (1985). Treatment of mice with 5-azacytidine efficiently activates fetal retroviral genomes in different tissues. Proc. Natl. Acad. Sci. USA 82, 1451-1455.
23. JAINCHILL, J.L., AARONSON, S.A., and TODORO, G.J. (1969). Murine sarcoma and leukemia viruses: Assay using clonal lines of contact inhibited mouse cells. J. Virol. 4, 549-553.
24. KAESTNER, K.H., HIEMISCH, H., LUCKOW, B., and SCHUTZ, G. (1994). The HNF-3-gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution. Genomics 20, 377-385.
25. KALEKO, M., GARCIA, J.V., and MILLER, A.D. (1991). Persistent gene expression after retroviral gene transfer into liver cells in vivo. Hum. Gene Ther. 2, 27-32.
26. 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc. Natl. Acad. Sci. USA 89, 89-93.
27. KAY, M.A., LI, Q., LIU, T.-J., LELAND, F., TOMAN, C., and WOO, S.L.C. (1992b). Hepatic gene therapy: persistent expression of human α-1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3, 641-647.
28. KAY, M.A., ROTHENBERG, S., LANDEN, C.N., BELLINGER, D.A., LELAND, F., TOMAN, C., FINEGOLD, M., THOMPSON, A.R., READ, M.S., BRINKHOUS, K.M., and WOO, S.L.C. (1993). In vivo gene therapy of hemophilia B: Sustained partial correction in Factor IX deficient dogs. Science 266, 117-119.
29. KRITIS, A.A., KITISTAKI, E., BARDA, D., ZANNIS, V.I., and TALIANIDIS, I. (1993). An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression. Nucleic Acids Res. 21, 5882-5889.
30. KUO, C.J., CONLEY, P.B., HSIEH, C.-L., FRANCKE, U., and CRABTREE, G.R. (1990). Molecular cloning, functional expression, and chromosomal localization of mouse hepatocyte nuclear factor 1. Proc. Natl. Acad. Sci. USA 87, 9838-9842.
31. KUO, C.J., CONLEY, P.B., CHEN, L., SLADEK, F.M., DARNELL, J.E., and CRABTREE, G.R. (1992). A transcriptional hierarchy involved in mammalian cell-type specification. Nature 355, 457-461.
32. LAI, E., PREZIOSO, V.R., SMITH, E., LITVIN, O., COSTA, R.H., and DARNELL, J.E., Jr. (1990). HNF-3α, A hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes & Dev. 4, 1427-1436.
33. LAI, E., CLARK, K.L., BURLEY, S.K., and DARNELL, J.E. (1993). Hepatocyte nuclear factor 3/forkhead or "winged helix" proteins: a family of transcription factors of diverse biologic function. Proc. Natl. Acad. Sci. USA 90, 10421-10423.
34. LANDSCHULTZ, W.H., JOHNSON, P.E., ADASHI, E.Y., GRAVES, B.J., and McKNIGHT, S.L. (1988). Isolation of a recombinant copy of the gene encoding C/EBP. Genes & Dev. 2, 786-800.
35. LI, Y., SHEN, R.-F., TSAI, S.Y., and WOO, S.L.C. (1988). Multiple hepatic trans-acting factors are required for in vitro transcription of the human alpha-1 antitrypsin gene. Mol. Cell. Biol. 8, 4362-4369.
36. LYNCH, C.M., CLOWES, M.M., OSBORNE, W.R.A., CLOWES, A.W., and MILLER, A.D. (1992). Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy. Proc. Natl. Acad. Sci. USA 89, 1138-1142.
37. MAIRE, P., WUARIN, J., and SCHIBLER, U. (1989). The role of cis-acting promoter elements in tissue-specific albumin gene expression. Science 244, 343-346.
38. MAJORS J. (1990). The structure and function of retroviral long terminal repeats. Curr. Topics Microbiol. Immunol. 157, 49-92.
39. MARKOWITZ, D., GOFF, S., and BANK, A. (1988). Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400-406.
40. McKNIGHT, S.L. (1992). CCAAT/enhancer binding protein. In Transcriptional Regulation. K.R. Yamamoto and S.L. McKnight eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
41. McCUNE, S.L., and TOWNES, T.M. (1994). Retroviral vector sequences inhibit human beta-globin gene expression in transgenic mice. Nucleic Acids Res. 22, 4477-4483.
42. MELTON, D.A., KRIEG, P.A., REBAGLIATI, M.R., MANIATAS, T., ZINN, K., and GREEN, M.R. (1984). Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12, 7035-7042.
43. MIETUS-SNYDER, M., SLADEK, F.M., GINSBURG, G.S., KUO, F., LADIAS, J.A.A., DARNELL, J.E., and KARATHANASIS, S.K. (1992). Antagonism between apolipoprotein A1 regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol. Cell. Biol. 12, 1708-1718.
44. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-990.
45. MONACI, P., NICOSIA, A., and CORTESE, R. (1988). Two different liver specific factors stimulate in vitro transcription from the human α1-antitrypsin promoter, EMBO J. 7, 2075-2087.
46. MUELLER, C.R., MAIRE, P., and SCHIBLER, U. (1990). DBP, a liver enriched transcriptional activator, is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally. Cell 61, 279-291.
47. NAKSHATRI, H., and CHAMBON, P. (1994). The directly repeated RG(G/T)TCA motifs of the rat and mouse cellular retinol-binding protein II genes are promiscuous binding sites for RAR, RXR, HNF-4, and ARP-1 homo- and heterodimers. J. Biol. Chem. 269, 890-902.
48. OVERDIER, D.G., PORCELLA, A., and COSTA, R.H. (1994). The DNA binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino acid residues adjacent to the recognition helix. Mol. Cell. Biol. 14, 2755-2766.
49. PALMER, T.D., ROSMAN, G., OSBORNE, W., and MILLER, A.D. (1991). Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88, 1330-1334.
50. PANI, L., OVERDIER, D.G., PORCELLA, A., QIAN, X., LAI, E., and COSTA, R.H. (1992). Hepatocyte nuclear factor 3 beta contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein. Mol. Cell. Biol. 12, 3723-3732.
51. PARKER, K.A., and BOND, U. (1989). Analysis of pre-rRNAs in heat shocked HeLa cells allow identification of the upstream termination site of human polymerase I transcription. Mol. Cell. Biol. 9, 2500-2512.
52. PAULWEBER, B., SANDHOFER, F., and LEVY-WILSON, B. (1993). The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3. Mol. Cell. Biol. 13, 1534-1546.
53. PONDER, K.P., DUNBAR, R., WILSON, D., DARLINGTON, G., and WOO, S.L.C. (1991). Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum. Gene Ther. 2, 41-52.
54. RETTINGER, S.D., KENNEDY, S.C., WU, X., SAYLORS, R.L., HAFENRICHTER, D.G., FLYE, M.W., and PONDER, K.P. (1994). Liver-directed gene therapy: Quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. USA 91, 1460-1464.
55. RICHARDS, C.A., and HUBER, B.E. (1993). Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression. Hum. Gene Ther. 4, 143-150.
56. SCHARFMANN, R., AXELROD, J.H., and VERMA, I.M. (1991). Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88, 4626-4630.
57. 1-antitrypsin gene is controlled by multiple cis-regulatory elements. Nucleic Acids Res.. 15, 8399-8415.
58. SLADEK, F.M., ZHONG, W. LAI, E., and DARNELL, J.E. Jr. (1990). Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes & Dev. 4, 2353-2365.
59. SORIANO P., FRIEDRICH, G., and LAWINGER, P. (1991). Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells. J. Virol. 65, 2314-2319.
60. STEWART, C.L., SCHUETZE, S., VANEK, M., and WAGNER, E.F. (1987). Expression of retroviral vectors in transgenic mice obtained by embryonic infection. EMBO J. 2, 383-388.
61. THOMASSIN, H., HAMEL, D., BERNIER, D., GUERTIN, M., and BELANGER, L. (1992). Molecular cloning of two C/EBP related proteins that bind to the promoter and enhancer of the alpha 1-feto-protein gene. Nucleic Acids Res. 20, 3091-3098.
62. TIAN, J.-M., and SCHIBLER, U. (1991). Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. Genes & Dev. 5, 2225-2234.